Imdelltra (tarlatamab-dlle) has shown statistically significant and clinically meaningful improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.

Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an oncologist recommends.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...